Compound Summary
药名: | DGN |
别名: | (2R)-2,5-diamino-5-oxopentanoic acid; C00819; ST5409906; NCGC00015472-01; 49410_FLUKA; NCGC00163333-01; CHEBI:17061; (2R)-2,5-diamino-5-oxo-pentanoic acid; 5959-95-5; InChI=1/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10; (2R)-2-amino-4-carbamoylbutanoic acid; (2R)-2,5-diamino-5-keto-valeric acid; (R)-2,5-diamino-5-oxopentanoic acid; D-Glutaminsaeure-5-amid; D-2-Aminoglutaramic acid; G9003_SIGMA; D-Glutamine; D-Glutamin; Lopac-G-3126; D-Glutamic acid 5-amide |
分子式: | C5H10N2O3 |
Smiles: | C(CC(=O)N)C(C(=O)O)N |
成分: | HBIN023533 |
OB_score: | 87.900228 |
CAS_id: | 5959-95-5 |
SymMap_id: | SMIT10768 |
TCMSP_id: | MOL009676 |
PubChem_id: | 145815 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE004459 | Fructus Lycii | 枸杞子 | To benefit the liver and the kidney, to replenish vital essence and to improve eyesight./Lassitude in lumbus and knees, emission, dizziness and dim vision, lung disease with cough, diabetes mellitus. |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000181 | PIM1 | PIM | Pim-1 proto-oncogene, serine/threonine kinase |
TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
TCMBANKGE000469 | CTSD | CLN10; CPSD; HEL-S-130P | cathepsin D |
TCMBANKGE000813 | DPP4 | ADABP; ADCP2; CD26; DPPIV; TP103 | dipeptidyl peptidase 4 |
TCMBANKGE000938 | CDK2 | CDKN2; p33(CDK2) | cyclin dependent kinase 2 |
TCMBANKGE000994 | AKR1B1 | ADR; ALDR1; ALR2; AR | aldo-keto reductase family 1 member B |
TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
TCMBANKGE006339 | CA2 | CA-II; CAC; CAII; Car2; HEL-76; HEL-S-282 | carbonic anhydrase 2 |
TCMBANKGE011079 | PRSS1 | TRP1; TRY1; TRY4; TRYP1 | serine protease 1 |
TCMBANKGE014050 | GABRA1 | ECA4; EIEE19; EJM; EJM5 | gamma-aminobutyric acid type A receptor subunit alpha1 |
TCMBANKGE014656 | ABAT | GABA-AT; GABAT; NPD009 | 4-aminobutyrate aminotransferase |